
This review explores current and emerging treatments for obesity-related asthma, a phenotype linked to poor outcomes. Existing therapies like metformin and GLP-1 receptor agonists show promise, though data remain limited. Monoclonal antibodies are generally effective, but obesity's impact on their efficacy in youth requires further study. Emerging targets include IL-6, arginine metabolites, and mitochondrial antioxidants. Transcriptomic studies highlight unique inflammatory pathways, paving the way for innovative therapies tailored to this complex condition.
Like
Save
Share